Dr. Markus Ploesser, MD

Dr. Ploesser practices at Dymphna San Diego TMS Inc in Chula Vista, California.

Dr. Ploesser's NPI, 1669662755, was assigned on July 26, 2007. Dr. Ploesser graduated from Humboldt University of Berlin - Charite Faculty of Medicine in 2001. Dr. Ploesser holds California license A101564.

Dr. Ploesser's primary practice is Dymphna San Diego TMS Inc, at 374 H St, Chula Vista, CA 91910 in San Diego County. The practice phone is (619) 510-8480.

Dr. Ploesser's primary practice is Dymphna San Diego TMS Inc in Chula Vista, California. Dr. Ploesser is also affiliated with Tisch Hospital. The medical group on file is Dymphna San Diego TMS, Inc. Dmand AI also links Dr. Ploesser to 12 more medical groups, 10 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ploesser practices, 12 sites in all. Vendor and product names are available with a free account.

Forensic psychiatry is Dr. Ploesser's primary specialty in the NPI Registry, under taxonomy code 2084F0202X. Dr. Ploesser is board certified in addiction medicine by the American Board of Preventive Medicine. Dmand AI has Dr. Ploesser's licenses on file in 9 states: California, Colorado, Massachusetts, Nevada, New York, District of Columbia, Hawaii, Washington and Oregon.

Dmand AI lists adjustment disease, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia, intellectual and developmental disabilities and non-alzheimer's dementia (chronic) among the conditions Dr. Ploesser treats.

CMS data shows 12,191 Medicare services from Dr. Ploesser across 13 procedure codes in 2024, for 1,131 Medicare patients. Medicare paid $963,829 for them.

CMS counts 1,131 Medicare patients who saw Dr. Ploesser in 2024. The largest group is 65 to 74, with 384 patients. 75% of them have depression, and 75% have high blood pressure. 78% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ploesser's median patient age at 68, with 52% women.

In 2024, Dr. Ploesser wrote 742 Medicare Part D claims for 70 patients. 85% of them were for generic drugs. CMS names the drug for 582 of them, across 20 drugs with 11 or more claims each, at $159,409 in total drug cost. In 2023, CMS named 705 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 13 out of 100 for Dr. Ploesser for performance year 2024, reported individually. Dr. Ploesser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ploesser as offering telehealth.

Dmand AI links 4 papers to Dr. Ploesser, published from 2022 to 2024. 2022 was the busiest year, with 2. Dr. Ploesser's most frequent co-authors are Sharona Ben-Haim, MD, Mickey Ellis Abraham, MD, MS and Brian Robert Hirshman, MD.

CMS Open Payments shows 619 general payments to Dr. Ploesser from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Alkermes, Inc. paid the most, $60,162.

Dr. Ploesser graduated from Humboldt University of Berlin - Charite Faculty of Medicine in 2001.

Dr. Ploesser is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.